EUVIMEDEUVIMED entdecken
Crossref

YAP Expression Confers Therapeutic Vulnerability to Cuproptosis in Breast Cancer Cells by Regulating Copper Homeostasis

Zei-Wei Liu, Cheng-Ying Chu, Yu-Ling Chen, Chu-Hung Chung, Fwu-Long Mi, Ming-Hua Ho, Wen-Jing Hsu, Ming-Yi Hsieh, Ming-Chen Chiang, Cheng-Jui Huang, Pei-Wei Shueng, Ching-Chieh Yang und 2 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202502769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Zei-Wei Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan. Hauptthemen laut MEDLINE: Copper, Breast Neoplasms, Homeostasis, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Far-Eastern Memorial Hospital, Chi Mei Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Copper metabolism plays a complex role in tumor growth and cancer progression and thus holds potential as a therapeutic target. However, reliable diagnostic markers and therapeutic tools for successfully predicting personalized treatment outcomes with copper inhibition remain elusive. In this study, it is discovered that Yes‐associated protein (YAP) expression conferred susceptibility toward cuproptosis. Molecular analyses revealed that YAP inhibition significantly abolished cuproptotic characteristics. Interestingly, YAP inhibition does not affect protein lipoylation but disrupts copper homeostasis. Mechanistically, YAP regulates antioxidant‐1 (ATOX1), a copper chaperone, and overexpression of ATOX1 restored cuproptotic sensitivity in YAP‐silenced cells. To advance copper‐targeting therapy, it is identified that melatonin inhibited YAP signaling and attenuated the expression of copper metabolism‐related genes. Furthermore, a copper‐based functional nanomaterial, EsMP@Fu is developed, which incorporates melatonin and the cuproptosis inducer elesclomol complex with copper ions (Cu(II)) (Es:Cu). This formulation facilitates cuproptotic cytotoxicity via fucoidan‐decorated nanocarrier to enhance the targeted delivery toward tumor cells. In vivo study demonstrated that EsMP@Fu significantly suppressed tumor growth by 60%, with more pronounced effects on distant metastasis and the induction of antitumor immunity. Collectively, the findings demonstrate that YAP overexpression confers sensitivity and therapeutic vulnerability to cuproptosis induction, presenting a promising strategy for precision medicine through tailored copper‐based therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperBreast NeoplasmsHomeostasisAdaptor Proteins, Signal TransducingTranscription FactorsHumansYAP-Signaling ProteinsFemaleAnimalsMiceCell Line, TumorMice, NudeMelatoninMice, Inbred BALB CCopper Transport ProteinsMolecular Chaperones

Stichwörter der Autor:innen

ATOX1YAPcopper homeostasiscuproptosisnanomedicine

Substanzen

CopperYAP-Signaling ProteinsYAP1 protein, humanAdaptor Proteins, Signal TransducingTranscription FactorsMelatoninATOX1 protein, humanCopper Transport ProteinsMolecular Chaperones

Autor:innen und Institutionen

  • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
  • Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan.
  • CRISPR Gene Targeting Core Lab, Taipei Medical University, Taipei, 11031, Taiwan.
  • Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, 106335, Taiwan.
  • Division of Radiation Oncology, Far Eastern Memorial Hospital, New Taipei City, 220216, Taiwan.
  • Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, 30010, Taiwan.

ORCID-Profile: Cheng-Wei Lin

Förderung

  • Ministry of Science and Technology, Taiwan
  • Far-Eastern Memorial Hospital
  • Chi Mei Medical Center

Zitieren

APA

Liu, Z. W., Chu, C. Y., Chen, Y. L., Chung, C. H., Mi, F. L., Ho, M. H., Hsu, W. J., Hsieh, M. Y., Chiang, M. C., Huang, C. J., Shueng, P. W., Yang, C. C., Lee, C. C., & Lin, C. W. (2026). YAP Expression Confers Therapeutic Vulnerability to Cuproptosis in Breast Cancer Cells by Regulating Copper Homeostasis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502769

Vancouver

Liu ZW, Chu CY, Chen YL, Chung CH, Mi FL, Ho MH, et al. YAP Expression Confers Therapeutic Vulnerability to Cuproptosis in Breast Cancer Cells by Regulating Copper Homeostasis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502769

BibTeX
@article{Liu2026,
  author = {Liu, Zei-Wei and Chu, Cheng-Ying and Chen, Yu-Ling and Chung, Chu-Hung and Mi, Fwu-Long and Ho, Ming-Hua and Hsu, Wen-Jing and Hsieh, Ming-Yi and Chiang, Ming-Chen and Huang, Cheng-Jui and Shueng, Pei-Wei and Yang, Ching-Chieh and Lee, Chi-Ching and Lin, Cheng-Wei},
  title = {YAP Expression Confers Therapeutic Vulnerability to Cuproptosis in Breast Cancer Cells by Regulating Copper Homeostasis},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202502769}
}
Kostenlos starten →